|
|
Volumn 9, Issue 4, 2000, Pages 917-928
|
|
Ongoing trials in HIV protease inhibitors
|
|
Author keywords
AIDS; Antiretrovirals; HIV; Protease inhibitors
|
|
Indexed keywords
ABACAVIR;
AMPRENAVIR;
AMPRENAVIR PHOSPHATE;
ATAZANAVIR;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
L 756423;
LAMIVUDINE;
LOPINAVIR;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TIPRANAVIR;
UNCLASSIFIED DRUG;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG STRUCTURE;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERCHOLESTEROLEMIA;
HYPERGLYCEMIA;
HYPERTRIGLYCERIDEMIA;
INSULIN RESISTANCE;
LIPODYSTROPHY;
META ANALYSIS;
NEPHROLITHIASIS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
REVIEW;
SALVAGE THERAPY;
|
|
EID: 0034104664
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.4.917 Document Type: Review |
|
Times cited : (10)
|
|
References (32)
|
